Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
FATE
Fate Therapeutics Inc.
19
Follow
19
FATE
Fate Therapeutics Inc.
19
Follow
19
Likes Subject
Older
(OT): InnDura Therapeutics is a preclinical stage company, jondoeuk 06/01/23 1:14 PM
(OT): The latest license is to Replay Bio jondoeuk 06/01/23 1:09 PM
Could be high TIL. I know MRK's Keytruda jondoeuk 06/01/23 1:05 PM
If NKX101 is successful, it would establish proof-of-concept, jondoeuk 06/01/23 1:01 PM
GMO is no match to organic NK. NY1972 05/29/23 10:28 AM
Why NKTX is not targeting cervical cancer? NY1972 05/27/23 6:03 PM
Why endometrial cancer? High TIL + high NK? NY1972 05/27/23 5:58 PM
Encouraging data that caused the stock to rise jondoeuk 05/27/23 5:19 PM
All these GMO cells is no match to NY1972 05/26/23 8:44 AM
''G-NK cells are associated with improved OS and jondoeuk 05/25/23 5:45 PM
Will load 4.70’ s again harry crumb 05/20/23 11:47 PM
(OT) Indapta Therapeutics announces FDA clearance of an jondoeuk 05/17/23 12:33 PM
Will load the 4.70 area again harry crumb 05/16/23 4:48 PM
It will be interesting to see the design jondoeuk 05/16/23 2:32 PM
Speaking of GD2 https://www.nature.com/articles/s41591-023-02363-y jondoeuk 05/15/23 6:49 PM
CGEM MICA/B good enough for a poster. So NY1972 05/11/23 10:34 PM
No, but with NKs you can have a jondoeuk 05/11/23 6:49 PM
A number won't, but both FATE (I'm negative jondoeuk 05/05/23 2:12 PM
Looking at 250 mil burn, FATE and other NY1972 05/03/23 11:34 PM
AFM28 - ADCP. NY1972 04/27/23 12:11 PM
Some CEOs won't even PR. AFMD was a NY1972 04/26/23 9:29 PM
A letter (dated April 4th) was received saying jondoeuk 04/25/23 11:50 PM
It has advantages as multiple edits can result jondoeuk 04/25/23 11:10 PM
If you listen to DTIL CSO who just NY1972 04/22/23 3:21 PM
TME is poorly understood. Mgt. is crossing a NY1972 04/22/23 3:17 PM
Clearly active (I wonder if they plan to jondoeuk 04/21/23 9:13 PM
An IIT (in China) testing this (using the jondoeuk 04/21/23 9:06 PM
Depends on the edits. The authors go on jondoeuk 04/21/23 9:01 PM
Endless edits still doesn't address the infection that NY1972 04/20/23 1:49 PM
What is the impact of multiple edits on NY1972 04/19/23 8:33 PM
Some more info on CLASH https://www.liebertpub.com/doi/10.1089/crispr.2023.0003 jondoeuk 04/19/23 7:13 PM
The poster jondoeuk 04/19/23 3:34 PM
I was hoping they would have focused on jondoeuk 04/19/23 3:30 PM
Out 6.60-6.65, $$$$$ harry crumb 04/18/23 3:08 PM
ICE that does ADCP has value. AFM 13 NY1972 04/16/23 8:10 PM
CAR NK looks like CART. What is the NY1972 04/13/23 10:04 AM
I can see why they chose the targets jondoeuk 04/11/23 4:07 PM
In this, the authors show that iPSC-derived NKs jondoeuk 04/05/23 5:59 PM
From twitter https://twitter.com/brendan_49/status/1636044757360164875 jondoeuk 03/17/23 3:17 PM
(OT) Cellinfinity Bio will leverage proprietary, directed evolution, jondoeuk 03/15/23 8:09 PM
Preclinical data on an anti-CXCR5 CAR https://www.nature.com/articles/s41467-020 jondoeuk 03/15/23 7:51 PM
Naturally, HLA-G blocks immune cell function by binding jondoeuk 03/15/23 6:53 PM
(OT) CARTemis Therapeutics jondoeuk 03/15/23 6:36 PM
Have you seen this in gene modified NK NY1972 03/15/23 3:27 PM
CAT-248, an allogeneic CD70-directed CAR-NK cell therapy effectively jondoeuk 03/14/23 10:08 PM
(OT) Catamaran Bio will use healthy donor NK jondoeuk 03/14/23 10:06 PM
Engineered iPSC-derived NK cells as next-generation immunotherapies for jondoeuk 03/14/23 9:44 PM
Identification of novel CAR transmembrane and endodomains for jondoeuk 03/14/23 9:41 PM
In this at 5.00 awhile back harry crumb 03/01/23 8:31 AM
Whats the story behind these lawsuits? Any thoughts harry crumb 02/17/23 11:15 PM
Likes Subject
Older

Older
jondoeuk
06/01/23 1:14 PM
jondoeuk
06/01/23 1:09 PM
jondoeuk
06/01/23 1:05 PM
jondoeuk
06/01/23 1:01 PM
NY1972
05/29/23 10:28 AM
NY1972
05/27/23 6:03 PM
NY1972
05/27/23 5:58 PM
jondoeuk
05/27/23 5:19 PM
NY1972
05/26/23 8:44 AM
jondoeuk
05/25/23 5:45 PM
harry crumb
05/20/23 11:47 PM
jondoeuk
05/17/23 12:33 PM
harry crumb
05/16/23 4:48 PM
jondoeuk
05/16/23 2:32 PM
jondoeuk
05/15/23 6:49 PM
NY1972
05/11/23 10:34 PM
jondoeuk
05/11/23 6:49 PM
jondoeuk
05/05/23 2:12 PM
NY1972
05/03/23 11:34 PM
NY1972
04/27/23 12:11 PM
NY1972
04/26/23 9:29 PM
jondoeuk
04/25/23 11:50 PM
jondoeuk
04/25/23 11:10 PM
NY1972
04/22/23 3:21 PM
NY1972
04/22/23 3:17 PM
jondoeuk
04/21/23 9:13 PM
jondoeuk
04/21/23 9:06 PM
jondoeuk
04/21/23 9:01 PM
NY1972
04/20/23 1:49 PM
NY1972
04/19/23 8:33 PM
jondoeuk
04/19/23 7:13 PM
jondoeuk
04/19/23 3:34 PM
jondoeuk
04/19/23 3:30 PM
harry crumb
04/18/23 3:08 PM
NY1972
04/16/23 8:10 PM
NY1972
04/13/23 10:04 AM
jondoeuk
04/11/23 4:07 PM
jondoeuk
04/05/23 5:59 PM
jondoeuk
03/17/23 3:17 PM
jondoeuk
03/15/23 8:09 PM
jondoeuk
03/15/23 7:51 PM
jondoeuk
03/15/23 6:53 PM
jondoeuk
03/15/23 6:36 PM
NY1972
03/15/23 3:27 PM
jondoeuk
03/14/23 10:08 PM
jondoeuk
03/14/23 10:06 PM
jondoeuk
03/14/23 9:44 PM
jondoeuk
03/14/23 9:41 PM
harry crumb
03/01/23 8:31 AM
harry crumb
02/17/23 11:15 PM

Fate Therapeutics Inc. (FATE)

Followers
19
Posters
37
Posts (Today)
0
Posts (Total)
289
Created
10/30/13
Type
Free
Moderators jondoeuk
Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
Upgrade to Real-Time
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Detailed Quote
FATE Latest News
More FATE News
Most Liked Posts
(Last 30 Days)
New Post